- Lobbying
- pharmaceutical AND research AND manufacturers AND of AND america
Lobbying Arrangements Results for 'Pharmaceutical Research Manufacturers Of America'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Independent Patient Advisory Board (IPAB) and Medicare Part D |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
G. Fox Consulting | |||
Details Any federal issues regarding the research and development of pharmaceuticals |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Dentons US LLP | |||
Details Issues related to pharmaceutical industry, generally |
Pharmaceutical Research and Manufacturers of America
|
RICCHETTI INCORPORATED | |||
Details Medicare |
Pharmaceutical Research and Manufacturers of America
|
Lesic and Camper Communications | |||
Details Health care reform, in particular biosimilars. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Ms. Rebecca Halkias | |||
Details Trade Association for certain Pharmaceutical Companies |
Pharmaceutical Research and Manufactures of America
|
Mr. Theodore (Ted) Jones | |||
Details Healthcare issues |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Wheat Government Relations | |||
Details Medicare, Medicaid, PDUFA and Patent Reform |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Mr. Derrick White | |||
Details Drug pricing and 340B |
Pharmaceutical Research and Manufacturers of America
|
Bose Public Affairs Group | |||
Details H.R. 6505 - Medicare Negotiation and Competitive Licensing Act of 2018; Medicare Part D |
Pharmaceutical Research and Manufacturers of America
|
Alexander J. Beckles, L.L.C. | |||
Details Health care reform issues affecting the pharmaceutical industry. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
PRICEWATERHOUSECOOPERS | |||
Details Trade Policy in Latin America |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
FTI Government Affairs | |||
Details WTO proposed Covid IP waiver |
Pharmaceutical Research and Manufacturers of America
|
Altrius Group, LLC | |||
Details Promoting pharmaceutical research and development and ensuring access to medicines. Issues related to antimicrobial resistance. |
Pharmaceutical Research and Manufacturers of America
|
Thorn Run Partners | |||
Details Assist client with legislative and regulatory initiatives of interest to research-based pharmaceutical industry. |
Pharmaceutical Research and Manufacturers of America
|
Barnes & Thornburg, LLP | |||
Details H.R. 5712, Physician Payment & Therapy Relief Act of 2010 |
Pharmaceutical Research and Manufacturers of America
|
Federal Strategy Group | |||
Details Ensuring adequate and effective intellectual property rights for pharmaceutical products in non-U.S. markets. |
The Pharmaceutical Research and Manufacturers of America (PhRMA)
|
CROWELL & MORING LLP | |||
Details Medicare Part D, Prescription Drug Program |
Pharmaceutical Research and Manufacturers of America
|
Prime Policy Group | |||
Details Drug safety issues. Pharmaceutical user fees. Foreign drug inspections. Drug reimportation. Direct to consumer advertising. |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
|
STUNTZ DAVIS & STAFFIER, P.C. | |||
Details 340B Drug Discount Program; Medicaid Drug Rebate Program Fiscal Year 2024 Appropriations bills |
Pharmaceutical Research and Manufacturers of America
|
SL STRATEGIES, LLC | |||
Details Issues relating to the design of Medicare Part D and Part B reimbursement of drugs and biologics in the Inflation Reduction Act. |
Pharmaceutical Research and Manufacturers of America
|
Federal Health Counsel, LLC | |||
Details General Medicare and Medicaid Issues. Prescription drug payment reform. Drug Pricing and Access. Pharmaceutical Supply Chain. Pharmacy Benefit Managers. |
Pharmaceutical Research and Manufacturers of America
|
LMH STRATEGIC SOLUTIONS | |||
Details Biopharmaceutical issues including: social and economic, value of the biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, and job impact. |
Pharmaceutical Research and Manufacturers of America
|
BRAVO GROUP | |||
Details Implementation of Health Care Reform Law, Patient Protection and Affordable Care Act of 2010, H.R. 3950 |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
|
Mr. DAVID MOHLER | |||
Details S.1542/H.R.6283, DRUG Act |
Pharmaceutical Research and Manufacturers of America
|
YC Consulting, LLC | |||
Details Inflation Reduction Act of 2022, PL 117-169 (drug pricing provisions) and other issues of relevance to the biopharmaceutical industry including prescription drug prices and importation of drugs. |
Pharmaceutical Research and Manufacturers of America
|
PutalaStrategies | |||
Details FY17 Appropriations Bills |
Pharmaceutical Research and Manufacturers of America
Pharmaceutical association. |
BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ | |||
Details Monitoring healthcare and drug pricing discussions, including implementation of the Inflation Reduction Act of 2022, H.R.5376, P.L.117-169. Issues related to policies concerning the pharmaceutical ... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
The Simmons & Russell Group, LLC | |||
Details HR 9 and any other legislation regarding patent law reform. |
Pharmaceutical Research and Manufactureres of America (PhRMA)
|
MCKENNA, LONG & ALDRIDGE | |||
Details Appropriations and budget committee issues VA, BioDefense |
Pharmaceutical Research and Manufacturers of America
|
WASHINGTON2 ADVOCATES | |||
Details HR 4173: Restoring American Financial Stability Act of 2010 S 3217: Restoring American Financial Stability Act of 2010 S____: Senate FTC Reauthorization Act of 2010 (Not introduced) |
Pharmaceutical Research & Manufacturers of America
|
Polsinelli Shughart PC | |||
Details Medicaid & Medicare COVID-19 Research and development of biopharmaceuticals Economic impact of the biopharmaceutical industry Research and development of biopharmaceuticals Inflation Reduction Act |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
KLINK CAMPAIGNS, INC | |||
Details Prescription Drug User Fee Act Independent Payment Advisory Board Medicare Part D Program |
Pharmaceutical Research and Manufacturers of America
to conduct effective advocacy for public policies |
MCGUIREWOODS CONSULTING | |||
Details Patent reform legislation, including S. 1145. |
Pharmaceutical Research and Manufacturers of America
|
WILMER CUTLER PICKERING HALE AND DORR LLP | |||
Details Issues related to The Patient Protection and Affordable Care Act (Public Law 111 148) |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
WHITMER & WORRALL, LLC | |||
Details water quality legislation, S.1005 patent law, S.515, H.R. 1260 |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
THE ACCORD GROUP | |||
Details WTO negotiations, free trade agreements, bilateral WTO accession agreements and other bilateral negotiations of interest to the research-based pharmaceutical industry. |
Pharmaceutical Research and Manufacturers of America (PhRMA)
Pharmaceutical research and biotechnology company trade association |
Preston Gates Ellis & Rouvelas Meeds LLP | |||
Details Agriculture Appropriations Labor HHS Appropriations Commerce, Justice, Science & Related Agencies Appropriations Homeland Security Appropriations |
Pharmaceutical Research & Manufacturers of America
|
Cornerstone Government Affairs, LLC | |||
Details Medicare and healthcare policy issues as they relate to drug pricing, CMMI, and Medicare Part D; including rebate system reforms |
Pharmaceutical Research and Manufacturers of America
|
Miller Strategies, LLC | |||
Details Developing support for issues that impact the development of new pharmacuetical products |
Pharmaceutical Research and Manufacturers of America
|
WATTS PARTNERS | |||
Details International intellectual property policy. Trade issues. |
Pharmaceutical Research and Manufacturers of America
|
ACG Advocacy | |||
Details Issues related to international trade; nominations to USTR and Commerce Issues related to intellectual property |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
TIGER HILL PARTNERS LLC | |||
Details Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid. |
Pharmaceutical Research and Manufacturers of America
|
BAKER & HOSTETLER LLP | |||
Details Issues relating to members on the International Trade Advisory Committees. |
Pharmaceutical Research and Manufacturing of America
|
Parven Pomper Strategies, Inc. | |||
Details Implementation of Patient Protection and Affordable Care Act of 2010 |
Pharmaceutical Research and Manufacturers of America
|
WALTER CONSULTING | |||
Details Education regarding market based solutions to bring down the cost of drug prices. Education regarding the dangers of global counterfeit medications. Education regarding the Part D program. Educatio... |
Pharmaceutical Research and Manufacturers of America (PhRMA)
|
Advanced Policy Consulting, LLC | |||
Details -Healthcare reform |
Pharmaceutical Research and Manufacturers of America
|
The Breaux Lott Leadership Group | |||
Details Pharmaceutical industry issues pertinent in WTO, FTA and other international negotiations and implementation |
Pharmaceutical Research & Manufacturers of America
|
SIDLEY AUSTIN LLP | |||
Details H.R. 923, Say No to Drug Ads Act H.R. 340/S. 528, Protecting Financial Aid for Students and Taxpayers Act H.R. 2831, To amend the Internal Revenue Code of 1986 to deny any deduction for marketing d... |
The Pharmaceutical Research and Manufacturers of America
pharmaceutical research and biotechnology companies |
Polsinelli PC | |||
Details Implementation of H.R.5376 Inflation Reduction Act. Issues related to the Medicaid Drug Rebate Program. Education about the 340(b) program. H.R.830 - HELP Copays Act. H.R.5378 - Lower Costs, ... |
Pharmaceutical Research and Manufacturers of America
|
W Strategies, LLC |